📰 Including Selective News
Page 2 - Including Selective News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Including Selective. Real-time updates on events, politics, business and more.
June 8, 2023
SAN DIEGO, June 08, 2023 -- Travere Therapeutics, Inc. today announced that the Company and its collaborators will present nine abstracts, including the interim analysis from the ongoing Phase 3... | June 10, 2023
May 1, 2023
The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secondary and topline exploratory endpoints trended favorably for sparsentan Treatment with... | May 1, 2023
May 1, 2023
The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secondary and topline exploratory endpoints trended...
April 1, 2023
FILSPARI demonstrated a statistically significant, rapid, and sustained decline of proteinuria compared to the active control...
April 1, 2023
SAN DIEGO, April 01, 2023 -- Travere Therapeutics, Inc. today announced publication in The Lancet of the interim analysis of efficacy and safety data from the ongoing pivotal, Phase 3 PROTECT... | April 1, 2023
April 1, 2023
SAN DIEGO, April 01, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced publication in The Lancet of the interim analysis of efficacy and safety data from the ongoing pivotal
March 23, 2023
SAN DIEGO, March 23, 2023 -- Travere Therapeutics, Inc. today announced that the interim analysis of efficacy and safety data from the ongoing Phase 3 PROTECT Study evaluating... | March 23, 2023